What is the effect of acetylcholinesterase inhibitors on cognitive function in Alzheimer’s treatment?

• A. Worsens cognitive decline
• B. Improves cognitive function
• C. No effect on cognitive function
• D. Causes sedation

Answer: (B)

Acetylcholinesterase inhibitors, such as donepezil, rivastigmine, and galantamine, are commonly used in the treatment of Alzheimer’s disease. These medications work by increasing the levels of acetylcholine in the brain by inhibiting the enzyme that breaks it down, acetylcholinesterase. In Alzheimer's disease, there is a significant decrease in acetylcholine which is associated with cognitive decline and memory loss. By preventing the breakdown of this neurotransmitter, acetylcholinesterase inhibitors can enhance cholinergic neurotransmission, leading to improved communication between nerve cells.

The improvement in cognitive function, as demonstrated in clinical studies, allows patients to maintain or enhance their memory, problem-solving abilities, and overall daily functioning for a period of time. Although these drugs do not cure Alzheimer’s disease, they may temporarily slow its progression and provide symptomatic relief, making a meaningful difference in the quality of life for patients and their caregivers.

Understanding the mechanism of action of these drugs provides insight into why they can result in cognitive improvements. The increase in acetylcholine helps address some of the cognitive deficits caused by the disease, making acetylcholinesterase inhibitors an important option in Alzheimer's treatment.